IL6 and ovarian carcinoma: Considering that IL-6 signalling is mainly mediated by the signal transducer and activator of transcription-3 (STAT3) pathway, we further explored whether an altered phosphorylated state of the tyrosine residue 705 (pY705) STAT3 protein may also influence the expression of TNFR2 phenotype in the ovarian cancer microenvironment.